Business press releases

Veracyte Announces Third Quarter 2026 Financial Results

Grew total revenue to $151.8 million and testing revenue to $146.4 million, representing 15% year-over-year growth

Ingram Micro Holding Corporation Announces Launch of Secondary Offering of 11,000,000 Shares of Common Stock by its Principal Stockholder and a Concurrent Stock Repurchase

PreTRM® test volume increases 54% sequentially and approximately five-fold from 1Q26

Ordering healthcare providers increase 34% sequentially and approximately three-fold from 1Q26

Unlikely Collaborators Awards $7.2 Million to Expand Perception Box Work at Nonprofits Nationwide

First national RFP supports 26 new nonprofit partners and continues funding for 26 organizations bringing Perception Box awareness into communities…

LeMaitre Q3 2026 Financial Results

Youlife Group Inc. Announces Initial US$3.0 Million Convertible Note Registered Direct Offering and Potential Additional Investments of Up to US$9.0 Million

Youlife Group Inc. ("Youlife" or the "Company") (NASDAQ: YOUL), a leading blue-collar lifetime service provider in China, today announced that it has…

Purple Innovation Reports Third Quarter 2026 Results

Positive Operating Cash Flow for the Third Consecutive Quarter Preparing for Major Mattress Portfolio Refresh to Strengthen Performance in 2027 LEHI,…

Coca-Cola Consolidated, Inc.

Coca-Cola Consolidated Reports

Amcor Reports Solid Results for

Quarter ended September 30, 2026

ALLEGIANT TRAVEL COMPANY

THIRD QUARTER 2026 FINANCIAL RESULTS*

Laza Medical Raises Up to $160 Million in Series B Financing Led by GE HealthCare to Advance Intelligent Imaging for Transforming the Cath Lab

Company's first-of-a-kind intelligent imaging system aims to expand patient access, streamline high-quality cardiac care, and establish the…

Advancing a neuromuscular franchise with claseprubart, a highly potent, investigational classical pathway inhibitor, with best-in-disease potential across generalized Myasthenia Gravis (gMG), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), and Multifocal Motor Neuropathy (MMN)

Phase 3 EMERGE registrational trial of claseprubart in gMG evaluating 300mg/2mL Q2W and 300mg/2mL Q4W on track, with top-line results expected in…

Chime Reports Third Quarter 2026 Financial Results

Revenue grows 32% year over year to $718 million

Snap Inc. Announces Third Quarter 2026 Financial Results

Third quarter revenue increased 14% year-over-year to $1,722 million

Outset Medical Reports Third Quarter 2026 Results

Granite Point Mortgage Trust Inc. Reports

Third Quarter 2026 Financial Results

Motorola Solutions Reports Third-Quarter 2026 Financial Results

Company raises full-year revenue and earnings outlook again and increases full-year cash flow expectations

The Braff Group Completes 400th Health Care Services M&A Transaction

Milestone reflects the firm's longstanding commitment to exclusively representing sellers in health care services mergers and acquisitions…

SVRN Appoints Patrick O'Kain as Chief Operating Officer

Former Borderless Capital General Partner, KPMG crypto practice co-lead, and U.S. Department of Justice special agent to lead SVRN's operations NEW…

Aeva Reports Third Quarter 2026 Results

Expanded Product Portfolio in Optical Connectivity with Ultra-High Power Sources and Modules to Address Significant and Growing Demand for AI Data…